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Dear Editor,  
 
Striate palmoplantar keratoderma (SPPK) (OMIM 148700) is an autosomal dominant genodermatosis 
characterized by linear hyperkeratosis of the volar aspects of the fingers extending onto the palm, 
associated with focal to diffuse hyperkeratosis of the soles.
1 
It is caused by heterozygous mutations in 
four different genes: desmoglein 1 (DSG1), desmoplakin (DSP), keratin 1 (KRT1) and keratin 16 
(KRT16).
1-4
  
We report three families, one Scottish, one English and one American, with autosomal 
dominant PPK, due to three previously unreported DSG1 mutations, where the presence of a striate 
pattern appears linked to the severity of the phenotype.  
 Family 1 presented to their local dermatology services. Families 2-3 were identified through 
the International Pachyonychia Congenita Research Registry. All reported having PPK since early 
childhood, with a positive family history in all pedigrees. No affected individuals had any history of 
skin fragility, blistering, nail, hair or cardiac abnormalities. Plantar pain was not a significant reported 
feature other than for the proband in family 2, whose palmar disease was severe, associated with his 
work as a manual labourer. 
 In family 1, all affected members had mild focal keratoderma of the palms and soles except 
for the proband’s brother, the most severe case in the family, who had striate keratoderma of the digits 
and palms bilaterally with the most severe focal pattern of the soles (Fig. 1a & Supplementary File, 
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S1, available from the author on direct request). In family 2, the proband, a 34 year-old male, had a 
striate pattern of severe hyperkeratosis affecting both palms with painful, multiple deep fissures over 
the distal palm and fingers, a diffuse hyperkeratosis of the soles affecting the weight bearing surfaces 
and a dominant family history (S1).  In family 3, the proband had a focal pattern of hyperkeratosis 
affecting the palms and soles (S1). A skin biopsy for histological assessment was declined by all 
patients. 
 Following written informed consent and ethical approval by a Western Institutional Review 
Board that complies with the Declaration of Helsinki, genomic DNA was extracted from peripheral 
blood leukocytes or from saliva collected in an Oragene DNA sample collection kit (DNA Genotek, 
Ontario, Canada).  
 Family 1 was initially screened for focal pattern PPK/pachyonychia congenita mutations by 
polymerase chain reaction (PCR) and direct DNA Sanger sequencing of the keratin genes KRT6A, 
KRT6B, KRT6C, KRT16 and KRT17, before proceeding to DSG1 gene screening.
1
 The coding region 
and intron/exon boundaries of DSG1 were amplified using primers specific to DSG1 (available on 
request). Purified PCR products were sequenced on an ABI 3730 Automated DNA sequencing 
machine (Foster City, CA). Families 2 and 3 were screened using a 9-gene panel, designed using 
Agilent SureSelect (at myGenomics, Alpharetta, USA), which included these 5 keratin genes, and 
DSG1, TRPV3, GJB6 and AAGAB, with pathogenic variants confirmed by Sanger sequencing. 
Variants were confirmed as pathogenic through sequencing unaffected and unaffected family 
members, and by reference to the in silico prediction tool, Mutation Taster. None of the variants were 
present on the database of Single Nucleotide Polymorphisms (dbSNP), 1000 Genome Project, NHLBI 
Exome Variant Server, Exome Aggregation Consortium (ExAC) or the Genome Aggregation 
Database (gnomAD).   
 A previously unreported 1 bp heterozygous deletion mutation in DSG1, c.376_376delT, 
leading to a frameshift and premature stop codon, p.Tyr126Thrfs*5 was identified in the proband of 
family 1 and in three additional affected family members; two unaffected family members were 
wildtype. The proband of family 2 had a previously unreported nonsense mutation, p.Trp303*; 
c.909G>A. The mutation was present in his affected mother but not in his unaffected father. Another 
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previously unreported nonsense mutation was identified in the proband of family 3, p.Leu337*; 
c.1010T>G; no other family members were available for screening. 
 It is postulated that DSG1 mutations (frameshift or nonsense) causing SPPK result in 
haploinsufficiency through nonsense mediated mRNA decay due to premature termination codons.
5 
Multiple mutations in DSG1, frameshift and nonsense, and very recently a missense mutation have 
been described causing inherited PPK with variations in the clinical patterns of keratoderma noted.
6,7
 
Although initially the majority of reported DSG1 mutations were associated with a striate pattern of 
hyperkeratosis, there is increasing evidence of non-striate patterns of keratoderma being present.
6,8
 
This series raises the possibility that only the more severe DSG1 phenotypes are associated with a 
striate pattern and that DSG1 screening should be considered routinely in focal PPK, particularly 
those with no plantar pain. 
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Figure Legends: 
 
Figure 1. (a) Pedigree of family 1 showing an autosomal dominant history of palmoplantar 
keratoderma. The arrow indicates the proband. 
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